We have demonstrated that CILP1 is significantly upregulated in both human and animal models of skin fibrosis, and its increased serum levels in HS patients suggest its utility as a novel biomarker for early diagnosis and progression monitoring. The gene discussed is CILP; the disease is histiocytic sarcoma.